Did you know?

This press release includes forward-looking statements about Verastem Oncology's strategy, future plans and prospects, including statements related to cash runway, the potential clinical value of various of its clinical trials, the timing of commencing and completing trials, including topline data reports, and potential for additional ...STOCKTWITS CHART ART: MAY 24, 2024The Stocktwits Summary 📝. It was a quiet day to close off a quiet week in the U.S. stock market, with the S&P 500 posting its smallest weekly change in more than three years. The S&P 500 and Nasdaq 100 continue to trade leadership places as investors try to identify the market's next leadership group.Join Us. At Verastem Oncology, every team member plays a key role in helping to develop novel cancer therapies in areas of high unmet need. If you’re looking to make a difference for patients at a company where you’ll constantly be challenged, where professional career growth is a priority, where you’ll always be heard, and where our ...Past Events. Date. Title. May 24, 2024 from 8:00 AM to 9:00 AM EDT. Verastem Oncology Corporate Update Call.

At Verastem Oncology, we’re on a mission to make sure no patient ever has to hear that news. We embrace the power of partnership and collaboration to develop novel cancer therapies. It’s through these collaborations that we’ll bring hope to patients with RAS pathway-driven cancers. Purposeful. Unwavering. Influential. Insightful.Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival ...GFH375/VS-7375. GFH375/VS-7375 is an orally bioavailable, potent and selective small molecule KRAS G12D (ON/OFF) inhibitor. Preclinical models demonstrate strong tumor regression as a single agent and support approaches in combination with Verastem Oncology's RAF/MEK clamp avutometinib as well as other rational combinations across KRAS G12D ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.The Verastem stock price fell by -66.17% on the last day (Friday, 24th May 2024) from $12.18 to $4.12. During the last trading day the stock fluctuated 30.60% from a day low at $4.02 to a day high of $5.25. The price has been going up and down for this period, and there has been a -65.23% loss for the last 2 weeks.

This presentation includes forward-looking statements about, among other things, Verastem Oncology’s programs and product candidates, including anticipated regulatory submissions, approvals, performance and potential benefits of Verastem Oncology’s product candidates, as well as Verastem Oncology’s potential income under its asset ...4.0600. -2.64%. Find the latest Verastem, Inc. (VSTM) stock quote, history, news and other vital information to help you with your stock trading and investing. ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Verastem stocktwits. Possible cause: Not clear verastem stocktwits.

Track Greenwave Technology Solutions Inc (GWAV) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsVerastem (NASDAQ: VSTM) just reported results for the fourth quarter of 2023. Verastem reported earnings per share of -$1.10. This was below the analyst estimate for EPS of -62 cents.

EPS. -$4.40. Price to Book. 11.61. Revenue Per Employee. N/A. Enterprise Value/EBITDA. -2.77. Get all financial information for Verastem Inc (VSTM) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and much more.Verastem Oncology is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index. Wikipedia. Headquarters: Massachusetts. Founded: 2010. CEO: Brian Stuglik (Jul 2019-)May 25, 2023 · Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed ...

open warrants hamilton county tennessee Verastem Oncology (Nasdaq: VSTM) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on RAS/MAPK-driven cancers, specifically novel small molecule drugs that inhibit critical signaling pathways in ...Track VistaGen Therapeutics Inc (VTGN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors joplin police department inmate rosterlifted craft cannabis buchanan reviews Insiders have sold a total of 16,432 Verastem shares in the last 24 months for a total of $168,350.95 sold. This page (NASDAQ:VSTM) was last updated on 5/25/2024 by MarketBeat.com Staff. toledo ohio missing persons The detail page will show you the real-time trend, you can click into the MSN Money website for more details magic notepaper rs3waitress 2023 showtimes near regal edwards alhambra renaissance and imaxghsa basketball standings Jeffersonville, Indiana is one of the best places to live in the U.S. in 2022 because of its low cost of living and ample things to do. Becoming a homeowner is closer than you thin... poughkeepsie journal obituaries past 30 days Fintel reports that on June 27, 2023, Truist Securities reiterated coverage of Verastem ( NASDAQ:VSTM) with a Buy recommendation. Analyst Price Forecast Suggests 393.85% Upside. As of June 2, 2023 ... zionsville homes for sale by ownerahmanson seating chart los angelesaarp jungle legend After Hours trades will be posted from 4:15 p.m. ET to 3:30 p.m. ET of the following day. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data ...